Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis | PLOS ONE
Monoclonal Gammopathy of Renal Significance Causes C3 Glomerulonephritis Via Monoclonal IgG Kappa Inhibition of Complement Factor H - Kidney International Reports
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
Cast Nephropathy and Deceptively Low Absolute Serum Free Light Chain Levels: Resolution of a Challenging Case and Systematic Review of the Literature - Clinical Lymphoma, Myeloma and Leukemia
The biology of immunoglobulin free light chains and kidney injury - Kidney International
Intrathecal kappa free light chains as markers for multiple sclerosis | Scientific Reports
Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone - Kidney International
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - The FEBS Journal - Wiley Online Library
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
A Fresh Perspective on Monoclonal Gammopathies of Renal Significance - Kidney International Reports
Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS | PLOS ONE
Mechanisms of Light Chain Injury along the Tubular Nephron | American Society of Nephrology
Kappa and Lambda Light Chains
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain